Natural history and effectiveness of early detection of Parkinson's disease: Results from two community-based programmes in Taiwan (KCIS no. 11)

Journal of Evaluation in Clinical Practice

Volumn 14, Issue 2, 2008, Pages 198-202

  Liou, Horng Huei ^a,b   Wu, Chia Yun ^c   Chiu, Yueh Hsia ^c   Yen, Amy Ming Fang ^c   Chen, Rong Chi ^d   Chen, Ta Fu ^a   Chen, Chih Chuan ^a   Hwang, Yuarn Chung ^e   Wen, Ying Rong ^f   Chen, Tony Hsiu Hsi ^c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d EN CHU KONG HOSPITAL   (Taiwan)

^e KEELUNG HOSPITAL   (Taiwan)

^f Department of Neurology   (Taiwan)

Author keywords

Early detection; Hoehn Yahr stage; Markov model; Parkinson's disease

Indexed keywords

ADULT; ARTICLE; COMMUNITY PROGRAM; DISABILITY; DISEASE DURATION; EARLY DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PARKINSON DISEASE; PRIORITY JOURNAL; SCREENING; SURVIVAL RATE; TAIWAN;

ADULT; COMMUNITY HEALTH SERVICES; COMPUTER SIMULATION; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PROGRAM EVALUATION; STATISTICS AS TOPIC; TAIWAN;

EID: 40449107427     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2007.00832.x     Document Type: Article

References (15)

1. Hoehn, M. M. Yahr, M. D. (1967) Parkinsonism: onset, progression and mortality. Neurology, 17, 427 442.
2. Marttila, P. J. Rinne UK. (1977) Disability and progression in Parkinson's disease. Acta Neurologica Scandinavica, 56, 159 169.
3. The Parkinson Study Group (1989) DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Archives of Neurology, 46, 1052 1060.
4. The Parkinson Study Group (1993) Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. New England Journal of Medicine, 328, 176 183.
5. Parkinson Study Group (1996) Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects not requiring levodopa. Annals of Neurology, 39, 29 36.
6. Parkinson Study Group (1996) Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subjects requiring levodopa. Annals of Neurology, 39, 37 45.
7. The Parkinson Study Group (1998) Mortality in DATATOP: a multicenter trial in early Parkinson's disease. Annals of Neurology, 43, 318 325.
8. Olanow, C. W., Hauser, R. A., Gauger, L., Malapira, T., Koller, W., Hubble, J., Bushenbark, K., Lilienfield, D. Esterlitz, J. (1995) The effect of deprenyl and levodopa on the progression of Parkinson's disease. Annals of Neurology, 38, 771 777.
9. Lee, C. S., Schulzer, M., Mak, E. K., Snow, B. J., Tsui, J. K., Calne, S., Hammerstad, J. Calne, D. B. (1994) Clinical observations on the rate of progression of idiopathic parkinsonism. Brain, 117, 501 507.
10. Chen, R. C., Chang, S. F., Su, C. L., Chen, T. H., Yen, M. F., Wu, H. M., Chen, Z. Y. Liou, H. H. (2001) Prevalence, incidence, and mortality of PD: a door-to-door survey in Ilan County. Taiwan Neurology, 57, 1679 1686.
11. Chen, T. H. H., Chiu, Y. H., Luh, D. L., et al. (2004) Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer, 100, 1734 1743.
12. Chen, T. H. H., Kuo, H. S., Yen, M. F., Lai, M. S., Tabar, L. Duffy, S. W. (2000) Estimation of sojourn time in chronic disease screening without data on interval cases. Biometrics, 56, 167 172.
13. Bonnet, A. M., Loria, Y., Saint-Hilaire, M. H., Lhermitte, F. Agid, Y. (1987) Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions? Neurology, 37, 1539 1542.
14. Poewe, W. H. Wenning, G. K. (1998) The natural history of Parkinson's disease. Annals of Neurology, 44 (3 Suppl. 1 S1 S9.
15. Fearnley, J. M. Lees, A. J. (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain, 114, 2283 2301.